Annual EBIT
-$145.54 M
-$37.95 M-35.27%
December 31, 2023
Summary
- As of February 7, 2025, ANAB annual earnings before interest & taxes is -$145.54 million, with the most recent change of -$37.95 million (-35.27%) on December 31, 2023.
- During the last 3 years, ANAB annual EBIT has fallen by -$125.61 million (-630.22%).
- ANAB annual EBIT is now -3123.89% below its all-time high of $4.81 million, reached on December 31, 2014.
Performance
ANAB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$17.44 M
+$18.26 M+51.15%
September 1, 2024
Summary
- As of February 7, 2025, ANAB quarterly earnings before interest & taxes is -$17.44 million, with the most recent change of +$18.26 million (+51.15%) on September 1, 2024.
- Over the past year, ANAB quarterly EBIT has increased by +$20.18 million (+53.65%).
- ANAB quarterly EBIT is now -146.76% below its all-time high of $37.29 million, reached on December 31, 2020.
Performance
ANAB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$128.01 M
+$15.44 M+10.76%
September 1, 2024
Summary
- As of February 7, 2025, ANAB TTM earnings before interest & taxes is -$128.01 million, with the most recent change of +$15.44 million (+10.76%) on September 1, 2024.
- Over the past year, ANAB TTM EBIT has increased by +$15.23 million (+10.63%).
- ANAB TTM EBIT is now -1163.66% below its all-time high of $12.04 million, reached on September 30, 2021.
Performance
ANAB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ANAB EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.3% | +53.6% | +10.6% |
| 3 y3 years | -630.2% | -161.6% | -1163.7% |
| 5 y5 years | -141.8% | +43.5% | -32.7% |
ANAB EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -158.3% | at low | at high | +56.3% | -127.2% | +12.0% |
| 5 y | 5-year | -630.2% | at low | -146.8% | +56.3% | -1163.7% | +12.0% |
| alltime | all time | -3123.9% | at low | -146.8% | +56.3% | -1163.7% | +12.0% |
AnaptysBio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.44 M(-51.2%) | -$128.01 M(-10.8%) |
| Jun 2024 | - | -$35.70 M(-5.1%) | -$143.45 M(+0.1%) |
| Mar 2024 | - | -$37.62 M(+1.0%) | -$143.24 M(-1.6%) |
| Dec 2023 | -$145.54 M(+35.3%) | -$37.26 M(+13.3%) | -$145.54 M(+11.6%) |
| Sep 2023 | - | -$32.88 M(-7.4%) | -$130.42 M(+4.4%) |
| Jun 2023 | - | -$35.49 M(-11.1%) | -$124.91 M(+7.6%) |
| Mar 2023 | - | -$39.92 M(+80.3%) | -$116.11 M(+7.9%) |
| Dec 2022 | -$107.59 M(+90.9%) | -$22.14 M(-19.1%) | -$107.59 M(-7.7%) |
| Sep 2022 | - | -$27.37 M(+2.6%) | -$116.54 M(+21.6%) |
| Jun 2022 | - | -$26.69 M(-15.0%) | -$95.84 M(+37.7%) |
| Mar 2022 | - | -$31.40 M(+1.0%) | -$69.58 M(+23.5%) |
| Dec 2021 | -$56.35 M(+182.7%) | -$31.09 M(+366.4%) | -$56.35 M(-568.2%) |
| Sep 2021 | - | -$6.67 M(+1453.8%) | $12.04 M(-313.6%) |
| Jun 2021 | - | -$429.00 K(-97.6%) | -$5.63 M(-79.8%) |
| Mar 2021 | - | -$18.16 M(-148.7%) | -$27.84 M(+39.7%) |
| Dec 2020 | -$19.93 M(-79.3%) | $37.29 M(-253.2%) | -$19.93 M(-74.2%) |
| Sep 2020 | - | -$24.34 M(+7.5%) | -$77.31 M(-7.8%) |
| Jun 2020 | - | -$22.64 M(+120.8%) | -$83.82 M(-1.3%) |
| Mar 2020 | - | -$10.25 M(-49.0%) | -$84.92 M(-11.9%) |
| Dec 2019 | -$96.45 M | -$20.09 M(-34.9%) | -$96.45 M(+3.5%) |
| Sep 2019 | - | -$30.84 M(+29.9%) | -$93.18 M(+19.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$23.74 M(+9.0%) | -$77.90 M(+15.7%) |
| Mar 2019 | - | -$21.78 M(+29.5%) | -$67.34 M(+11.9%) |
| Dec 2018 | -$60.20 M(+112.7%) | -$16.82 M(+8.1%) | -$60.20 M(+20.9%) |
| Sep 2018 | - | -$15.56 M(+18.0%) | -$49.78 M(+16.1%) |
| Jun 2018 | - | -$13.18 M(-9.9%) | -$42.86 M(+34.3%) |
| Mar 2018 | - | -$14.63 M(+128.5%) | -$31.92 M(+12.8%) |
| Dec 2017 | -$28.30 M(+644.4%) | -$6.41 M(-25.9%) | -$28.30 M(+7.4%) |
| Sep 2017 | - | -$8.64 M(+284.8%) | -$26.36 M(+40.8%) |
| Jun 2017 | - | -$2.25 M(-79.6%) | -$18.72 M(+33.4%) |
| Mar 2017 | - | -$11.01 M(+146.4%) | -$14.04 M(+269.2%) |
| Dec 2016 | -$3.80 M(-20.9%) | -$4.47 M(+347.1%) | -$3.80 M(+43.9%) |
| Sep 2016 | - | -$999.00 K(-141.0%) | -$2.64 M(-10.1%) |
| Jun 2016 | - | $2.44 M(-415.4%) | -$2.94 M(-44.7%) |
| Mar 2016 | - | -$773.00 K(-76.6%) | -$5.32 M(+10.6%) |
| Dec 2015 | -$4.81 M(-199.9%) | -$3.31 M(+155.0%) | -$4.81 M(+386.9%) |
| Sep 2015 | - | -$1.30 M(-2261.7%) | -$987.00 K(-126.2%) |
| Jun 2015 | - | $60.00 K(-122.9%) | $3.77 M(+1.6%) |
| Mar 2015 | - | -$262.00 K(-151.2%) | $3.71 M(-6.6%) |
| Dec 2014 | $4.81 M(-203.3%) | $512.00 K(-85.2%) | $3.97 M(+14.8%) |
| Sep 2014 | - | $3.46 M | $3.46 M |
| Dec 2013 | -$4.66 M | - | - |
FAQ
- What is AnaptysBio annual earnings before interest & taxes?
- What is the all time high annual EBIT for AnaptysBio?
- What is AnaptysBio annual EBIT year-on-year change?
- What is AnaptysBio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AnaptysBio?
- What is AnaptysBio quarterly EBIT year-on-year change?
- What is AnaptysBio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AnaptysBio?
- What is AnaptysBio TTM EBIT year-on-year change?
What is AnaptysBio annual earnings before interest & taxes?
The current annual EBIT of ANAB is -$145.54 M
What is the all time high annual EBIT for AnaptysBio?
AnaptysBio all-time high annual earnings before interest & taxes is $4.81 M
What is AnaptysBio annual EBIT year-on-year change?
Over the past year, ANAB annual earnings before interest & taxes has changed by -$37.95 M (-35.27%)
What is AnaptysBio quarterly earnings before interest & taxes?
The current quarterly EBIT of ANAB is -$17.44 M
What is the all time high quarterly EBIT for AnaptysBio?
AnaptysBio all-time high quarterly earnings before interest & taxes is $37.29 M
What is AnaptysBio quarterly EBIT year-on-year change?
Over the past year, ANAB quarterly earnings before interest & taxes has changed by +$20.18 M (+53.65%)
What is AnaptysBio TTM earnings before interest & taxes?
The current TTM EBIT of ANAB is -$128.01 M
What is the all time high TTM EBIT for AnaptysBio?
AnaptysBio all-time high TTM earnings before interest & taxes is $12.04 M
What is AnaptysBio TTM EBIT year-on-year change?
Over the past year, ANAB TTM earnings before interest & taxes has changed by +$15.23 M (+10.63%)